Velpanat Tablet: Sofosbuvir 400mg + Velpatasvir 100mg
Looking for Velpanat Tablet containing Sofosbuvir (400mg) + Velpatasvir (100mg) for pharmaceutical procurement in Washington, USA? Start with the exact product label, manufacturer details, batch information and documentation. These details help buyers assess an offer before discussing price or delivery.
This page provides product and procurement information for importers, pharmaceutical distributors, wholesalers and healthcare procurement teams. Ernest Impex LLP is the business enquiry contact. Current availability and eligibility for the proposed transaction require confirmation.
What Is Velpanat Tablet?
Velpanat is a NATCO Pharma brand associated with the combination of sofosbuvir and velpatasvir. NATCO lists it within its gastroenterology and hepatology portfolio.
Sofosbuvir and velpatasvir are direct-acting antiviral medicines used together in the treatment of chronic hepatitis C. They target different processes the virus needs to reproduce.
The combination is used against hepatitis C genotypes 1–6 in appropriate patients. Treatment selection depends on the patient’s liver condition, previous treatment and other clinical factors. The particular product’s approved prescribing information should guide its use. hcp.epclusa.com
Key Benefits of the Combination
The main therapeutic benefit of sofosbuvir and velpatasvir is treating chronic hepatitis C, with the aim of achieving a sustained virologic response. This means the virus remains undetectable on the relevant test after treatment.
The formulation brings two antiviral ingredients together in one tablet. Its activity across multiple hepatitis C genotypes is an important feature of the combination. These benefits do not guarantee an individual outcome or establish U.S. approval for the Velpanat brand. hcp.epclusa.com
Buyers reviewing hepatitis C medicines should keep the brand, composition and market presentation clearly identified in their purchasing records.
Product Specifications
| Specification | Details |
|---|---|
| Brand name | Velpanat Tablet |
| Composition per tablet | Sofosbuvir 400mg + Velpatasvir 100mg |
| Product category | Direct-acting antiviral combination |
| Dosage form | Tablet |
| Route | Oral |
| Manufacturer supplied for this listing | Natco Pharma Ltd.; verify the offered pack |
| Business enquiry contact | Ernest Impex LLP |
| Labelled marketer | Verify from the actual carton |
| Pack quantity | Confirm against the offered presentation |
| Shelf life | Confirm from the current batch |
| Storage | Follow the actual product label |
| Target audience | Importers, distributors, wholesalers and healthcare procurement teams |
Ernest Impex LLP is identified here as the procurement contact. Its status as the labelled marketer or an authorised NATCO distributor has not been independently established.
Important Clinical Information
Hepatitis C antiviral treatment requires medical assessment. The prescribing information for the sofosbuvir/velpatasvir combination warns about hepatitis B reactivation and calls for testing for current or previous hepatitis B infection before treatment.
Medicine interactions also matter. Amiodarone can cause serious slowing of the heart rate when used with sofosbuvir-containing regimens, while some other medicines can reduce antiviral effectiveness. A clinician should review the patient’s complete medicine list. hcp.epclusa.com
This procurement page does not provide dosing or treatment-duration advice.
Quality Checks Before Approving an Order
For bulk purchasing, compare the physical pack with the quotation and supporting records. Check that the brand, ingredient strengths and quantity are consistent.
Request:
- Readable photographs of the actual carton and container.
- Matching batch numbers and expiry dates.
- Manufacturer and manufacturing-site details.
- Traceable invoices and source-of-supply records.
- Available batch documentation, including a certificate of analysis where obtainable.
Agree on the minimum remaining shelf life before placing the order. For example, if your organisation requires a specific period before expiry, include it in the purchase specification rather than leaving it to a verbal discussion.
Use pharmaceutical quality checks as an internal-link point where a relevant page already exists.
What Washington Buyers Need to Verify
NATCO’s domestic portfolio page carries a notice stating that the molecule is available for sale only in India. Buyers should therefore confirm the applicable territorial supply restrictions before considering a Washington transaction.
U.S. approval of a medicine containing the same ingredients does not automatically establish approval or import eligibility for Velpanat. FDA checks applicable requirements such as drug approval, registration, listing, labelling and manufacturing compliance when medicines are offered for import.
This listing should not be read as confirmation of routine Velpanat supply in the United States.
Clear Documents Build Buyer Confidence
A useful quotation should identify the exact brand, pack quantity, number of packs, price basis, remaining shelf life and delivery terms. Ask which product and commercial documents can be provided for the specific transaction.
Keep document purposes clear. A commercial invoice records the sale, while a certificate of analysis reports specified batch tests. Neither independently establishes permission to distribute the product in every market.
For storage and transport, use the conditions printed on the offered pack. Link medicine storage and transport to an existing relevant guidance page if available.
Procurement Enquiries Through Ernest Impex LLP
Send your organisation details, required quantity, preferred pack presentation, destination and documentation needs. Specify whether the delivery address is in Washington State or Washington, D.C.
Contact Ernest Impex LLP to request product information and an assessment of the enquiry. Confirm territorial restrictions and U.S. eligibility before any purchase or shipment commitment.
Frequently Asked Questions
1. What does Velpanat Tablet contain?
The requested formulation contains Sofosbuvir 400mg and Velpatasvir 100mg per tablet. Confirm both strengths on the actual product label.
2. What is the combination used for?
Sofosbuvir and velpatasvir are used to treat chronic hepatitis C in appropriate patients. Clinical assessment and the applicable prescribing information determine treatment suitability. hcp.epclusa.com
3. Who is the manufacturer?
Natco Pharma Ltd. is the manufacturer supplied for this listing, and NATCO identifies Velpanat in its portfolio. Verify the manufacturer and site on the offered pack.
4. What should wholesalers check before purchase?
Confirm the pack quantity, ingredient strengths, batch details, expiry, packaging condition, source records and available quality documents. Resolve any discrepancies before accepting the stock.
5. Does this page confirm availability in Washington, USA?
No. Territorial supply restrictions and eligibility for the exact U.S. transaction must be established first. NATCO’s domestic page includes an India-only sales notice.
